NEFL and sarcopenia: Furthermore, circulating biomarkers such as growth differentiation factor-15 (GDF15), C-terminal agrin fragment (CAF), neurofilament light chain (NfL), and inflammatory indices have been investigated for their correlation with muscle mass, strength, and sarcopenia status in COPD patients [16, 27-29].